Cargando…

Proactive Risk Assessment through Failure Mode and Effect Analysis (FMEA) for Perioperative Management Model of Oral Anticoagulant Therapy: A Pilot Project

Introduction: Correct perioperative management of anticoagulant therapy is essential to prevent thromboembolic events and reduce the risk of bleeding. The lack of universally accepted guidelines makes perioperative anticoagulant therapy management difficult. The present study aims to identify the pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Micheletta, Fausta, Ferrara, Michela, Bertozzi, Giuseppe, Volonnino, Gianpietro, Nasso, Maria, La Russa, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779206/
https://www.ncbi.nlm.nih.gov/pubmed/36554313
http://dx.doi.org/10.3390/ijerph192416430
_version_ 1784856553050865664
author Micheletta, Fausta
Ferrara, Michela
Bertozzi, Giuseppe
Volonnino, Gianpietro
Nasso, Maria
La Russa, Raffaele
author_facet Micheletta, Fausta
Ferrara, Michela
Bertozzi, Giuseppe
Volonnino, Gianpietro
Nasso, Maria
La Russa, Raffaele
author_sort Micheletta, Fausta
collection PubMed
description Introduction: Correct perioperative management of anticoagulant therapy is essential to prevent thromboembolic events and reduce the risk of bleeding. The lack of universally accepted guidelines makes perioperative anticoagulant therapy management difficult. The present study aims to identify the perioperative risks of oral anticoagulant therapy and to reduce adverse events through Failure Mode and Effect Analysis (FMEA). Materials and Methods: A multidisciplinary working group was set up, and four main phases of the process were identified. Each of these phases was divided into micro-activities to identify the related possible failure modes and their potential consequences. The Risk Priority Number was calculated for each failure mode. Results and Discussion: Seventeen failure modes were identified in the entire perioperative period; those with a higher priority of intervention concern the incorrect timing between therapy suspension and surgery, and the incorrect assessment of the bleeding risk related to the invasive procedure. Conclusion: The FMEA method can help identify anticoagulant therapy perioperative failures and implement the management and patient safety of surgical procedures.
format Online
Article
Text
id pubmed-9779206
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97792062022-12-23 Proactive Risk Assessment through Failure Mode and Effect Analysis (FMEA) for Perioperative Management Model of Oral Anticoagulant Therapy: A Pilot Project Micheletta, Fausta Ferrara, Michela Bertozzi, Giuseppe Volonnino, Gianpietro Nasso, Maria La Russa, Raffaele Int J Environ Res Public Health Article Introduction: Correct perioperative management of anticoagulant therapy is essential to prevent thromboembolic events and reduce the risk of bleeding. The lack of universally accepted guidelines makes perioperative anticoagulant therapy management difficult. The present study aims to identify the perioperative risks of oral anticoagulant therapy and to reduce adverse events through Failure Mode and Effect Analysis (FMEA). Materials and Methods: A multidisciplinary working group was set up, and four main phases of the process were identified. Each of these phases was divided into micro-activities to identify the related possible failure modes and their potential consequences. The Risk Priority Number was calculated for each failure mode. Results and Discussion: Seventeen failure modes were identified in the entire perioperative period; those with a higher priority of intervention concern the incorrect timing between therapy suspension and surgery, and the incorrect assessment of the bleeding risk related to the invasive procedure. Conclusion: The FMEA method can help identify anticoagulant therapy perioperative failures and implement the management and patient safety of surgical procedures. MDPI 2022-12-07 /pmc/articles/PMC9779206/ /pubmed/36554313 http://dx.doi.org/10.3390/ijerph192416430 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Micheletta, Fausta
Ferrara, Michela
Bertozzi, Giuseppe
Volonnino, Gianpietro
Nasso, Maria
La Russa, Raffaele
Proactive Risk Assessment through Failure Mode and Effect Analysis (FMEA) for Perioperative Management Model of Oral Anticoagulant Therapy: A Pilot Project
title Proactive Risk Assessment through Failure Mode and Effect Analysis (FMEA) for Perioperative Management Model of Oral Anticoagulant Therapy: A Pilot Project
title_full Proactive Risk Assessment through Failure Mode and Effect Analysis (FMEA) for Perioperative Management Model of Oral Anticoagulant Therapy: A Pilot Project
title_fullStr Proactive Risk Assessment through Failure Mode and Effect Analysis (FMEA) for Perioperative Management Model of Oral Anticoagulant Therapy: A Pilot Project
title_full_unstemmed Proactive Risk Assessment through Failure Mode and Effect Analysis (FMEA) for Perioperative Management Model of Oral Anticoagulant Therapy: A Pilot Project
title_short Proactive Risk Assessment through Failure Mode and Effect Analysis (FMEA) for Perioperative Management Model of Oral Anticoagulant Therapy: A Pilot Project
title_sort proactive risk assessment through failure mode and effect analysis (fmea) for perioperative management model of oral anticoagulant therapy: a pilot project
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779206/
https://www.ncbi.nlm.nih.gov/pubmed/36554313
http://dx.doi.org/10.3390/ijerph192416430
work_keys_str_mv AT michelettafausta proactiveriskassessmentthroughfailuremodeandeffectanalysisfmeaforperioperativemanagementmodeloforalanticoagulanttherapyapilotproject
AT ferraramichela proactiveriskassessmentthroughfailuremodeandeffectanalysisfmeaforperioperativemanagementmodeloforalanticoagulanttherapyapilotproject
AT bertozzigiuseppe proactiveriskassessmentthroughfailuremodeandeffectanalysisfmeaforperioperativemanagementmodeloforalanticoagulanttherapyapilotproject
AT volonninogianpietro proactiveriskassessmentthroughfailuremodeandeffectanalysisfmeaforperioperativemanagementmodeloforalanticoagulanttherapyapilotproject
AT nassomaria proactiveriskassessmentthroughfailuremodeandeffectanalysisfmeaforperioperativemanagementmodeloforalanticoagulanttherapyapilotproject
AT larussaraffaele proactiveriskassessmentthroughfailuremodeandeffectanalysisfmeaforperioperativemanagementmodeloforalanticoagulanttherapyapilotproject